We are live on
!
Find out more
SRIM
Saratoga Research & Investment Management Portfolio holdings
AUM
$1.83B
1-Year Est. Return
18.41%
This Fund
S&P 500
This Quarter
Est. Return
+0.44%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$2.17B
AUM Growth
+$45.9M
(+2.2%)
Cap. Flow
+$47.2M
Cap. Flow
% of AUM
2.18%
Top 10 Holdings %
Top 10 Hldgs %
50.32%
Holding
46
New
3
Increased
17
Reduced
19
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$42.2M |
| 2 |
Unilever
UL
|
+$17.9M |
| 3 |
C.H. Robinson
CHRW
|
+$12.5M |
| 4 |
3M
MMM
|
+$7.6M |
| 5 |
Microsoft
MSFT
|
+$7.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$38.9M |
| 2 |
PepsiCo
PEP
|
+$8.94M |
| 3 |
Cisco
CSCO
|
+$6.65M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$3.98M |
| 5 |
Oracle
ORCL
|
+$2.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.88% |
| 2 | Industrials | 16.23% |
| 3 | Healthcare | 15.81% |
| 4 | Consumer Staples | 10.27% |
| 5 | Communication Services | 10.19% |
Similar funds
SI
DWT
OQS
RP
HMC
ABTD
FCIM
CPSAC
Saratoga Research & Investment Management's Q3 2021 Portfolio in Review
As of Q3 2021, Saratoga Research & Investment Management held 46 positions worth $2.17B, up 2.2% from $2.12B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Saratoga Research & Investment Management's Q3 2021 filing shows 3 new, 17 increased and 19 reduced positions. Its largest new stake was Adobe: 1,029 shares worth $592K. The largest sale was Novo Nordisk, an estimated $38.9M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.
- Saratoga Research & Investment Management's largest Q3 2021 buy was Adobe: 1,029 shares worth $592K.
- Saratoga Research & Investment Management added most to Visa in Q3 2021, an estimated $42.2M increase.
- Saratoga Research & Investment Management's biggest Q3 2021 reduction was Novo Nordisk, cutting an estimated $38.9M.
- Saratoga Research & Investment Management's ten largest holdings make up 50% of its $2.17B portfolio in Q3 2021.
- Saratoga Research & Investment Management opened 3 new positions and closed 0 in Q3 2021.
- Saratoga Research & Investment Management's portfolio value rose 2.2% quarter-over-quarter to $2.17B.
Based on Saratoga Research & Investment Management's 13F filing for Q3 2021, filed 5 Nov 2021.